Breaking

Bold Stakes Claims Near Springpole and Grants Options
Cizzle Brands Unveils its Team of Ambassadors to Accelerate North American Commercialization Initiatives
Pro-lifers pounce on Fetterman for opposing ‘Born-Alive Abortion Survivors Protection Act’: ‘Infanticide’
Top 5 moments from Trump’s ‘Hannity’ interview
‘Stealing American jobs’: Anti-CCP group unleashes ad demanding GOP lawmakers back Trump on saving US farms
With Gaza quiet, Israel is turning its focus on the West Bank. Here’s why
Ireland finally appoints new prime minister after chaos in parliament
Stardust Power Breaks Ground on One of The Largest U.S. Battery-Grade Lithium Refineries

Politics
Business
World
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Cizzle Brands Unveils its Team of Ambassadors to Accelerate North American Commercialization Initiatives

January 23, 2025

Bold Stakes Claims Near Springpole and Grants Options

January 23, 2025

Stardust Power Breaks Ground on One of The Largest U.S. Battery-Grade Lithium Refineries

January 23, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,415)
- Investing (3,719)
- Politics (5,597)
- World (4,956)

Disclaimer: thesuccessfulsociety.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2023 thesuccessfulsociety.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.